Security key
140755109
Cara Therapeutics, Inc. - Common Stock, par value $0.001 per share (CARA)
CUSIP: 140755109
Q3 2023 13F Holders as of 30 Sep 2023
- Security type / class
- Equity / Common Stock, par value $0.001 per share
- Total 13F shares
- 27,123,062
- Total 13F value
- $45,563,127
- Share change
- -2,190,718
- Put/Call ratio
- 25%
- SEC-reported price per share
- $1.68
- Number of holders
- 121
- Value change
- -$6,587,024
- Number of buys
- 50
- Number of sells
- 70
- Shares outstanding
- 54,790,889
Holder snapshot
7 signals
Show 1 more signal
Security identity
1 source field
Report period
Q3 2023
Institutions
121
Top holders
10
CARA full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q4 2023
Previous quarter: Q2 2023
Tvardi Therapeutics, Inc. SEC filings
Tvardi Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 140755109
Recent filing periods:
Ownership snapshot
Top reported holders of CARA - Cara Therapeutics, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
BlackRock Finance, Inc.
Disclosed value leader
BlackRock Finance, Inc.
Comparable rows
15/15
Latest evidence
30 Jun 2023
13F
Lead comparable stake: 6.8%
Showing 1-6 of 15 holder rows.
Quick read
BlackRock Finance, Inc. leads the comparable SEC ownership view at 6.8%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Comparable ownership
Top 5
BlackRock Finance, Inc.
6.8%
VANGUARD GROUP INC
4.7%
DISCIPLINED GROWTH INVESTORS INC /MN
3.2%
FARALLON CAPITAL MANAGEMENT LLC
3%
Chescapmanager LLC
3%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| BlackRock Finance, Inc. |
13F
Company
|
6.8%
|
$10,476,570
3,701,968 shares
|
— | 30 Jun 2023 |
| VANGUARD GROUP INC |
13F
Company
|
4.7%
|
$7,340,958
2,593,978 shares
|
— | 30 Jun 2023 |
| DISCIPLINED GROWTH INVESTORS INC /MN |
13F
Company
|
3.2%
|
$4,992,689
1,764,201 shares
|
— | 30 Jun 2023 |
| FARALLON CAPITAL MANAGEMENT LLC |
13F
Company
|
3%
|
$4,716,453
1,666,591 shares
|
— | 30 Jun 2023 |
| Chescapmanager LLC |
13F
Company
|
3%
|
$4,685,280
1,655,576 shares
|
— | 30 Jun 2023 |
| JACOBS LEVY EQUITY MANAGEMENT, INC |
13F
Company
|
1.9%
|
$2,894,756
1,022,882 shares
|
— | 30 Jun 2023 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2023
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
121
Shares
27,123,062
Rows available
121
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2023 vs Q2 2023 Across Filers
Q2 2023 holders
131
Q3 2023 holders
121
Holder diff
-10
| Investor | Q2 2023 Shares | Q3 2023 Shares | Share Diff | Share Chg % | Q2 2023 value | Q3 2023 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend